What is Highgrade Labs?
Highgrade Labs operates as an ISO-accredited, multi-state cannabis testing laboratory, established in 2019. The company specializes in a comprehensive suite of assessments for cannabis and CBD products, including critical analyses such as mycotoxin testing and residual solvent analysis. Leveraging state-of-the-art technology, Highgrade Labs ensures the delivery of accurate and timely results to its clientele. Its operational footprint spans New Jersey, Maryland, and Oklahoma, serving businesses within the burgeoning cannabis industry. The firm places a strong emphasis on client education and regulatory compliance, assisting businesses in navigating the complex and evolving cannabis regulatory environment.
How much funding has Highgrade Labs raised?
Highgrade Labs has raised a total of $3.8M across 1 funding round:
Unspecified
$3.8M
Unspecified (2020): $3.8M, investors not publicly disclosed
What's next for Highgrade Labs?
The recent major strategic investment signifies a pivotal moment for Highgrade Labs, likely enabling expansion of its testing capabilities, geographical reach, or technological infrastructure. As the cannabis industry continues to mature and regulatory scrutiny intensifies, Highgrade Labs is strategically positioned to capitalize on the increasing demand for reliable and compliant product testing. Future growth may involve further technological innovation, strategic partnerships, or acquisitions to solidify its market leadership and enhance its service offerings across key states.
See full Highgrade Labs company page
